Article Details

Matinas BioPharma Announces Positive Opinion by the - GlobeNewswire

Retrieved on: 2022-07-25 10:32:40

Tags for this article:

Click the tags to see associated articles and topics

Matinas BioPharma Announces Positive Opinion by the - GlobeNewswire. View article details on hiswai:

Excerpt

BEDMINSTER, N.J., July 25, 2022 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up